IP Library Granted Patent US 8,080,425
Granted Patent B2
US 8,080,425 · App. 12/343,847 · Granted Dec 20, 2011

Quantitative analysis of a biological sample of unknown quantity

Assignee: Home Access Health Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,080,425
App. No.
12/343,847
Granted
Dec 20, 2011
Kind
B2
Abstract

Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.

Claims (22)

1. A method for determining a level of an analyte in blood from a solution formed from a dried blood fluid specimen eluted with a fluid, the blood fluid specimen being a plasma or serum specimen, comprising:

in any order, measuring a first level of an analyte in said solution, measuring the level of a first normalizing analyte in said solution, and measuring the level of a second normalizing analyte in said solution; and

calculating the level of the analyte in the specimen from which said modified specimen was collected based on said first level of the analyte in said solution, the level of said first normalizing analyte in said solution, and the level of said second normalizing analyte in said solution by calculating the weighted average of the level of said first and said second normalizing analyte in said solution.

2. The method of claim 1 , wherein said blood fluid specimen comprising a dried whole blood specimen.

3. The method of claim 1 , wherein said analyte is a cholesterol.

4. The method of claim 1 , wherein said analyte is a ALT.

5. The method of claim 1 , wherein said analyte is PSA.

6. The method of claim 1 , wherein said first or second normalizing analyte is chloride.

7. The method of claim 1 , wherein said first or second normalizing analyte is osmolality.

8. A method for determining the level of an analyte from a solution formed from a dried blood fluid specimen eluted with a fluid, comprising:

in any order, measuring a first level of an analyte in said solution, measuring the level of a first normalizing analyte in said solution, and measuring at least one other normalizing analyte in said solution; and

calculating the level of the analyte in the blood from which said blood fluid specimen was collected based on said first analyte level in said solution, the level of said first normalizing analyte in said solution, and the level of at least one other normalizing analyte in said solution by calculating an average of the level of said first and at least two other normalizing analytes in said solution.

9. The method of claim 8 , wherein said analyte is a cholesterol.

10. The method of claim 8 , wherein said analyte is a ALT.

11. The method of claim 8 , wherein said analyte is PSA.

12. The method of claim 8 , wherein said first or said at least one other normalizing analyte is chloride.

13. The method of claim 8 , wherein said first or said at least one other normalizing analyte is osmolality.

14. The method of claim 8 , further comprising:

calculating the first level of analyte in said solution; and calculating the level of the analyte in the blood from which said blood fluid specimen was collected by multiplying said first level of analyte in said solution by a correction factor, said correction factor being calculated as a function of the level of the first or the at least one other normalizing analyte in said solution.

15. A method of reporting a test result comprising a level of analyte calculated according to the method of claim 8 , the method comprising: receiving an incoming inquiry from a user; prompting said user for a test number; retrieving a test result from a database of test numbers and test results; and reporting said test results to said user.

16. A method for preparing a database of test results comprising a level of analyte calculated according to the method of claim 8 , the method comprising: receiving a test number; receiving a test result; and storing said test result and said test number in a database record.

17. The method of claim 8 , wherein said first and the at least other normalizing analytes are dissimilar and are each selected from the group consisting of sodium, chloride, and osmolality.

Assignments (3)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT REEL/FRAME NO. 55879/0989 Recorded May 28, 2025
From: CRG SERVICING LLC, AS ADMINISTRATIVE AGENT
To: PWNHEALTH CHICAGO LLC
Reel/Frame 071454/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2021
From: HOME ACCESS HEALTH CORPORATION
To: PWNHEALTH CHICAGO LLC
Reel/Frame 056408/0695 →
SECURITY INTEREST Recorded Apr 9, 2021
From: PWNHEALTH CHICAGO LLC
To: CRG SERVICING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 055879/0989 →
Continuity (3)
Division 10421086 · Apr 23, 2003
Provisional Application 60374629 · Apr 23, 2002
Related Publication 20090104636A1 · Apr 23, 2009